¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13
±³À°ÀÏÀÚ : 2020-03-13
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿ÈúÈ£ÅÚ VISTA  
±³À°ÁÖÁ¦ : 2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ)
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï 100,000¿ø ÇöÀåµî·Ï 200,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-13 VISTA 1 09:00~09:20 The Evil Side of Gene Regulation in AML  Ruud delwel(Erasmus MC University 'The Netherlands) 
±³À°½Ã°£ 03-13 VISTA 1 09:20~09:40 Clonal Evolution under IDH Inhibitor Therapy in Acute Myeloid Leukaemia  Lynn Quek UK(University of Oxford UK) 
±³À°½Ã°£ 03-13 VISTA 1 09:40~10:00 TET Loss-of-Function in Malignant Hematopoiesis  Myunggon Ko(UNIST) 
±³À°½Ã°£ 03-13 VISTA 1 10:00~10:30 NRAS Mutant AML  Taebo Sim(KU-KIST) 
±³À°½Ã°£ 03-13 VISTA 1 10:45~11:15 Translational Cancer Research in B-Cell Malignancies  John Gribben(Barts Cancer Institute UK) 
±³À°½Ã°£ 03-13 VISTA 1 11:15~11:45 Myelodysplastic Syndrome and Predisposition to Myeloid Neoplasia in Children and Adolescents  Charlotte Niemeyer(University of Freiburg Germany) 
±³À°½Ã°£ 03-13 VISTA 1 11:45~12:05 Outcome of Autologous Transplant in T Cell Lymphoma: Experience of NIHBT in Vietnam  Nguyen Vu Bao Anh(Hanoi Medical University Vietnam) 
±³À°½Ã°£ 03-13 VISTA 1 12:05~12:25 Subcutaneous Panniculitis-like T-cell Lymphoma  Udomsak Bunworasate(King Chulalongkorn Memorial Hosptal Thailand) 
±³À°½Ã°£ 03-13 VISTA 1 12:25~12:45 Update of Extranodal NK/T-cell Lymphoma: Treatment and Biology  Seok Jin Kim(Sungkyunkwan University) 
±³À°½Ã°£ 03-13 VISTA 1 12:45~13:40 Optimizing Treatment of IMiDs in Newly Diagnosed Multiple Myeloma  Philippe Moreau(Nantes University Hospital France) 
±³À°½Ã°£ 03-13 VISTA 1 14:10~15:10 Heterogeneous outcome after allogeneic stem cell transplantation according to type of KIT mutation in Core binding factor acute myeloid leukemia (CBF-AML): D816V and/or D816Y mutation represents worst outcome  Silvia Park(Catholic University of Korea) 
±³À°½Ã°£ 03-13 VISTA 1 15:25~16:25 Clinical Significance Of Genetic And Epigenetic Expression of PTEN In Chronic Myeloidic Leukemia Patients  Asgar Ali(India Institute of Medical Sciences Patna India) 
±³À°½Ã°£ 03-13 VISTA 1 16:40~17:10 Challenges in the Diagnosis of Bone Marrow Failure Syndromes: The Role of Genetic Panels?  Ghulam J Mufti(King's College Hospital UK) 
±³À°½Ã°£ 03-13 VISTA 1 17:10~17:40 Clonal Hematopoesis in Bone Marrow Failure  Daria V. Babushok(University of Pennsylvania USA) 
±³À°½Ã°£ 03-13 VISTA 1 17:40~18:10 he Current Treatment Algorithm for Patients with Acquired Aplastic Anemia in Japan  Shinji Nakao(Kanazawa University Japan) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ 14th Asian-Australasian Federation of Intervention and Therapeutic Neuroradiology (AAFITN 2020) : 2020-03-13
´ÙÀ½±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ 14th Asian-Australasian Federation of Intervention and Therapeutic Neuroradiology (AAFITN 2020) : 2020-03-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 3 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 4 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 5 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 3 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 5 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 5 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷